Farxiga and Xigduo Diabetes Drug Makers Face MDL in New York
The Judicial Panel on Multidistrict Litigation established a multidistrict litigation (MDL) in New York to hear claims of diabetic ketoacidosis and kidney damage allegedly caused by the Farxiga and Xigduo diabetes drugs. Farxiga and its sister drug Xigduo XR are manufactured by Bristol-Myers Squibb Co., AstraZeneca Pharmaceuticals … [Read more...] about Farxiga and Xigduo Diabetes Drug Makers Face MDL in New York
Invokana’s Link to Ketoacidosis Allegedly Hidden by Janssen and J&J
A Florida woman alleges, in a recent lawsuit brought against the makers of Invokana--Janssen Pharmaceuticals, and its parent company Johnson & Johnson (J&J)--, that the drug makers neglected to issue a proper warning about the connection between Invokana and ketoacidosis, a condition that occurs when too much acid builds up … [Read more...] about Invokana’s Link to Ketoacidosis Allegedly Hidden by Janssen and J&J
Lawsuit Alleges Invokana Responsible for Diabetic Ketoacidosis Injury
A lawsuit filed against Johnson & Johnson and its subsidiary, Janssen, alleges that the Janssen diabetes medication, Invokana, causes patients to develop diabetic ketoacidosis. The lawsuit was filed in the Court of Common Pleas, Philadelphia County, and includes allegations that the manufacturers of Invokana (canagliflozin) … [Read more...] about Lawsuit Alleges Invokana Responsible for Diabetic Ketoacidosis Injury
